Azelaic acid market seen topping $415 million by 2033

The global azelaic acid market is expected to grow steadily through 2033 as demand rises for dermatology treatments and specialty industrial uses. Allied Market Research says pharma-grade material and plastics applications are set to lead the market.

Why it matters: - Azelaic acid is moving from a niche skincare ingredient into a broader growth market across pharmaceuticals, cosmetics and plastics. - The market’s expansion reflects rising demand for treatments for acne, rosacea, melasma and hyperpigmentation, plus industrial use in plastics manufacturing. - The global market is projected to reach $415.3 million by 2033, up from a 2024 base, with growth driven by a 7.2% CAGR from 2024 to 2033.

What happened: - Allied Market Research projected the azelaic acid market will grow from USD 218.29 million in 2022 to USD 422.21 million by 2032, at a CAGR of 7.0%. - The firm also said the global azelaic acid market is projected to reach $415.3 million by 2033. - The outlook was published June 23, 2026, in Wilmington, Delaware. - The report covers market growth by type, application, end user and region. - The report is available as a sample here. - Purchase options are listed here. - The full summary report is available here.

The details: - Azelaic acid is a naturally occurring dicarboxylic acid found in cereal grains such as wheat, rye and barley, as well as in animal products. - The ingredient is used as a topical treatment for acne, rosacea and skin discoloration. - Azelaic acid has anti-inflammatory, antimicrobial, comedolytic, keratolytic and antioxidant properties. - Prescription products are sold in gel, foam and cream forms, including Azelex and Finacea. - Over-the-counter products typically contain 10% to 12% azelaic acid, while prescription products contain more than 15%. - The pharma-grade segment is expected to hold the largest share through the forecast period because of its high purity and strict quality standards. - The plastics segment is expected to hold the highest market share during the projected timeframe because azelaic acid acts as a polymerization catalyst for engineering plastics such as polyamides. - The report says plastics demand is supported by applications in automotive, electronics and industrial markets. - The market report evaluates companies by product offering, geographic presence, business strategy, segment share and SWOT analysis. - The report also reviews company developments including product launches, innovations, joint ventures, partnerships, mergers and acquisitions and strategic alliances. - Major players named in the report include BASF, Croda International plc, Nantong Hengxing Electronic Materials Co Ltd, Wufeng Chicheng Biotech Co., Ltd., Xi'an Sonwu Biotech Co., Ltd., Emery Oleochemicals, Haihang Industry Corporation, Nantong Jinghua Pharmaceutical Co., Ltd., Jiangsu Senxuan Pharmaceutical and Chemical Co Ltd, Matrìca S.p.A., LG Chem, Evonik Industries AG and Solvay SA.

Between the lines: - The growth case is being shaped by two different demand pools: skin-care and drug-development uses on one side, and industrial plastics on the other. - The report also points to friction that could slow adoption, including low awareness, regional regulatory differences and competition from alternative treatments. - Pharma-grade leadership suggests the market still depends heavily on regulated, higher-value applications rather than mass consumer exposure alone.

What's next: - Allied Market Research expects pharmaceutical research to keep expanding azelaic acid’s role in dermatological care. - Market competition is likely to stay active as companies pursue partnerships, product development and other strategic moves. - Regional approvals and consumer education will remain important variables for how quickly the market scales.

The bottom line: - Azelaic acid is on track for steady growth, with medical uses, cleaner-ingredient demand and industrial plastics applications all supporting the long-term outlook.